Biosimulation Market to Generate US$ 7 Billion by 2030 | Growth & Key Business Strategies

The Linkedin Influencer Marketing Bundle For Your Business But Under $100
The growth of the global biosimulation market can be attributed to significant rise in spending on R&D by pharmaceutical and biotechnology companies. Additionally, high cost associated with re-conducting clinical trials, owing to the high failure rate in phase III clinical trials contributes to the adoption of biosimulation in drug discovery and drug development, which, in turn, boosts the growth of the market.

Read the source article at financedigest.com
2021-11-22 10:04:00